Acting as a Responsible Person (import) (RPi): MHRA concretises Eligibility Criteria

Recommendation
Wednesday, 30 April 2025 9 .00 - 17.30 h
How to Audit Logistics Service Providers
Since 1 January 2021, a wholesale dealer in Great Britain may only import Qualified Person (QP) certified medicines from the European Economic Area if certain checks are made by the Responsible Person (import) (RPi).
Last year, the Medicines and Healthcare products Regulatory Agency (MHRA) has published a Guidance called "Acting as a Responsible Person (import) ". The guidance describes the role of the Responsible Person (import) (RPi) and how to become a RPi. A summary can be found in our news archive. The guidance was now updated, listing extensive qualification requirements for RPi's.
Becoming a Responsible Person (import)
There are two stages to becoming named as a RPi: First the eligibility must be demonstrated. This is through a combination of relevant qualifications and experience. Furthermore, suitability must be demonstrated to be named on a specific WDA(H) licence.
Qualifications
According to the updated guidance, acceptable qualifications are "a diploma, certificate or other evidence of formal qualifications awarded on completion of a university or other higher education course of study in:
- pharmacy
- chemistry
- medicine
- biology or
- a related life science
Equivalent qualifications acceptable for RPi candidates include:
- Level 5 qualifications from Chartered Institute of Logistics and Transport
- A Quality Management System Lead Auditor or Pharmaceutical GMP Lead Auditor qualification awarded by Chartered Quality Institute
Other qualifications may also be acceptable."
Candidates must be able to demonstrate, for example by providing a curriculum vitae (CV), that they have a minimum of 2 years’ experience in performing the functions of a responsible person on a WDA(H). "Evidence of performing other functions, for example a quality assurance role for a pharmaceutical manufacturer, may also be considered equivalent."
For more information, please see the Guidance "Acting as a Responsible Person (import)".
Related GMP News
11.03.2025USP Publishes Summary of Comments on Chapter <1079.2> Regarding Mean Kinetic Temperature (MKT)
11.03.2025EMA: No further Extension of GDP Certificates in 2025
11.03.2025Aide-Mémoires and Checklists in GDP Audits - Benefits and Risks
13.02.2025MHRA updates Guidance on Sourcing Medicines for the UK Market
13.02.2025First GDP Non-Compliance Report of 2025: Data Integrity Issues at Hungarian Wholesaler